BML-190 is primarily researched for its potential role in modulating cannabinoid receptors, particularly CB2 receptors. It is often used in scientific studies to investigate the effects of cannabinoid receptor activity on inflammation and immune responses. Researchers utilize it to explore therapeutic possibilities in conditions like chronic pain, autoimmune diseases, and neurodegenerative disorders. Its selective action on CB2 receptors makes it a valuable tool for understanding the endocannabinoid system and developing targeted treatments without the psychoactive effects associated with CB1 receptor activation.